Sofwave: Ultrasound Skin Tightening Cost, Results and Reviews

Sofwave is the brand name for the SofWave System, a non-invasive dermatological aesthetic device made by Sofwave Medical Ltd. of Israel.

It is cleared through the FDA's 510(k) device pathway.

It is not FDA-approved, and this page keeps that distinction throughout.

The current clearance, K250146, is dated April 18, 2025.

It describes the SofWave System as a non-invasive treatment to improve facial lines and wrinkles, lift the eyebrow, and lift lax submental — beneath the chin — and neck tissue in people aged 22 and older.

The same clearance covers short-term improvement in the appearance of cellulite, acne scars, and skin laxity on the upper arms.

The device has been on the US market longer than that date suggests.

Its first US clearance, K191421, came on September 9, 2019 — under the name "Sofacia System" — for improving facial lines and wrinkles in people 22 and older.

The eyebrow, neck/submental, cellulite, acne-scar and upper-arm indications were added through later 510(k)s between 2021 and 2025.

Under the hood, the FDA's 510(k) summary describes the applicator as an array of ultrasonic transducers emitting continuous acoustic waves at 10–12 MHz, with an active cooling element that cools the skin in contact with it.

Heating the dermis this way creates controlled, isolated areas of thermal damage.

Sofwave's own description is more specific.

The company says its SUPERB technology — Synchronous Ultrasound Parallel Beam — uses 7 parallel beam transducers, that the thermal effect sits between 0.5 and 2 mm deep, centered at 1.5 mm (mid-dermis), and that the dermis is heated to 60–70°C.

Those depth and temperature figures are the manufacturer's own.

One wording note: for the brow and the submental and neck areas, the cleared text says lift. "Skin tightening" is the shorthand patients and practices use for this category, including in this page's title, but lift is the word the clearance uses.

The FDA clearance names the treatment areas.

Sofwave is cleared as a non-invasive treatment for:

• improving facial lines and wrinkles
• lifting the eyebrow
• lifting lax submental (beneath the chin) and neck tissue
• short-term improvement in the appearance of cellulite
• short-term improvement in the appearance of acne scars
• short-term improvement in skin laxity on the upper arms

The lines, brow and submental/neck indications are cleared for people aged 22 and older.

A treatment area or claim outside this list is not a cleared use of the device.

On skin types: Sofwave's patient page says "Sofwave is FDA-cleared to treat all skin types." The FDA's cleared indications text does not mention skin types at all, so that statement is Sofwave's own claim, not an FDA determination.

Sofwave's safety information also lists situations where the treatment should not be used:

• pregnancy or breastfeeding, or giving birth less than 3 months ago
• a pacemaker or other electronic implant in the area
• metal stents or implants in the face
• open wounds
• severe or cystic acne
• active infection
• isotretinoin or another retinoid within the past 6 months
• anti-platelet, anti-coagulant or psychiatric drugs within the past 2 weeks

The same safety information says treatment directly over dermal filler is not recommended, so a practice needs to know about any filler before a session is booked.

This list comes from the maker rather than the FDA, and a licensed provider will weigh your health history and medications before deciding whether the treatment makes sense for you.

Start with what we cannot tell you: we could not verify a national average price for Sofwave.

The American Society of Plastic Surgeons' 2025 procedural statistics release does not report counts or fees for minimally invasive procedures, so no current ASPS average fee exists for Sofwave, and our research found no other current national figure we could stand behind.

The prices you see quoted online may be one practice's number rather than a benchmark.

What we can say is how the treatment is priced.

Sofwave-based treatment is priced per session, and the number of sessions is a main driver of the total.

Sofwave says treatment is typically a single session of 30–45 minutes, so a practice that recommends more than one session is quoting you for more than one visit.

When you collect quotes, ask what each price includes: which areas are treated, how many sessions the practice recommends and why, whether a package is priced differently from a single session, and what a touch-up costs if the practice offers one.

With no national figure to compare against, quotes from a few practices near you are the only real numbers you will have.

For more on pricing, see how much Sofwave costs.

Sofwave says most treatments take 30–45 minutes, and describes a typical course as one session.

The company's own before-and-after gallery complicates that picture slightly: some of its photos are labeled "After 2 treatments." Ask any practice you consult how many sessions they recommend for your areas, and why.

How long results last is a question we cannot answer from the sources we checked.

We could not confirm a duration for Sofwave results, and we will not invent one — treat any month count you see online as unverified, and ask each practice how long their patients' results have held and how they follow up.

The before-and-after photos themselves are worth reading carefully.

Sofwave's own gallery shows results photographed at widely varying times after treatment — from 4–6 weeks to 3 months and up to 10 months — and labels some photos with treatment counts.

Compare photos only at similar time points and treatment counts.

That caution applies to reviews and social posts too.

Under the FTC Endorsement Guides, a result shown in an ad is read as representative of what consumers will generally achieve, and the FTC says disclaimers like "results not typical" are generally insufficient on their own.

Manufacturer before-and-afters are often labeled with the number of treatments and the time point, so check the treatment count, the time since treatment, the lighting and whether the photos are unretouched.

None of it predicts what your own result will be.

Discomfort is a real possibility.

Sofwave's own safety information lists significant pain among the anticipated adverse events of its ultrasound treatment — the full list is in the risks section below — and the company does not publish rates saying how often it occurs.

We could not confirm a typical comfort level from the sources we checked, so it is a fair question to ask each practice: what they use to keep patients comfortable during a session.

Downtime is similar territory.

We could not confirm a recovery time for Sofwave from the sources we checked.

The maker lists persistent redness and swelling among possible adverse events, again without rates, so the honest position is that the company's materials do not give a figure we can quote.

A practice can tell you what recovery usually looks like in its own patients; that answer is experience rather than data, but it is what you have.

On the shape of the appointment itself: Sofwave says most treatments take 30–45 minutes, and the FDA text describes the treatment as non-invasive.

Sofwave's safety information lists the anticipated adverse events of ultrasound-based treatment as significant pain, tenderness, changes in skin pigmentation, persistent redness and swelling, ulceration/erosion and/or bruising.

That is the maker's list, and it comes without rates: Sofwave does not say how often any of these occur, so we cannot tell you the odds.

Two practical notes.

First, the candidacy section above lists the situations where the maker says Sofwave should not be used — including treatment directly over dermal filler — which is why the health-history conversation matters more than the machine.

Second, because the company publishes no frequency figures, a practice's own complication history is the only rate data our sources give you; asking for it is reasonable.

The two other energy devices our comparison sources put alongside Sofwave at med spas are Ultherapy (micro-focused ultrasound, from Ulthera, part of Merz) and Thermage FLX (monopolar radiofrequency, from Solta Medical).

All three are FDA-cleared devices, not FDA-approved drugs, and they are not interchangeable — the clearances cover different things.

The energy differs.

Per FDA documents, Sofwave is parallel-beam ultrasound at 10–12 MHz focused in the dermis — Sofwave says the thermal effect is centered at 1.5 mm.

Ulthera is micro-focused ultrasound with real-time imaging that visualizes up to 8 mm below the skin. Thermage FLX is monopolar radiofrequency at 6.78 MHz.

The "lift versus tighten" question has a factual answer at the clearance level: Ultherapy and Sofwave both carry clearances that say lift — the eyebrow and lax submental and neck tissue — while Thermage FLX's clearance is written for wrinkles and rhytids and does not use the word lift.

Anything beyond the cleared wording is a manufacturer's claim, not cleared language.

What we did not find is a head-to-head trial.

Our research located no clinical trial comparing Sofwave directly with Ultherapy, or Thermage with Ultherapy, so no claim that one device is "proven better" than another has a study behind it.

Comparisons rest on each device's own clearance and each company's own statements.

One name not to confuse: Pure Impact, now marketed as PureImpact VIP, is a Sofwave-made device too, but it is electrical muscle stimulation, not ultrasound.

It was cleared (K251746, July 2, 2025) for improving abdominal tone and strengthening muscles of the arms, thighs and buttocks, and a user selects either ultrasound or EMS — not both.

Which device fits you depends on the area, your anatomy and your goals — a conversation for a licensed provider who treats with these devices.

For the category as a whole, our skin tightening options guide compares the ultrasound, radiofrequency and laser approaches.

Two things decide whether a Sofwave treatment goes well: who operates the device, and how honestly the practice quotes the work.

Both are checkable.

AmSpa, a med spa trade association, says that injecting a prescription drug such as botulinum toxin is the practice of medicine because it affects living tissue, so it must be done by a physician, an independent-practice nurse practitioner or another licensed professional working within their scope, under rules that vary by state.

For a device like Sofwave, we could not confirm a national rule on who may operate it.

Ask each practice directly: who will operate the Sofwave system, what license that person holds, and what training they have on this specific device.

Questions worth asking before you book:

For the full vetting process — credentials to look for, the consultation, pricing red flags and ownership — our how to choose a med spa checklist goes deeper.

When you search for Sofwave providers near you, the same checks apply: a consultation is where you get the real numbers for your areas, the person who would treat you, and the session count that practice actually recommends.